JP2010524435A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524435A5
JP2010524435A5 JP2010501433A JP2010501433A JP2010524435A5 JP 2010524435 A5 JP2010524435 A5 JP 2010524435A5 JP 2010501433 A JP2010501433 A JP 2010501433A JP 2010501433 A JP2010501433 A JP 2010501433A JP 2010524435 A5 JP2010524435 A5 JP 2010524435A5
Authority
JP
Japan
Prior art keywords
seq
cdr
set forth
region
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
JP2010501433A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524435A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/002663 external-priority patent/WO2008119566A2/en
Publication of JP2010524435A publication Critical patent/JP2010524435A/ja
Publication of JP2010524435A5 publication Critical patent/JP2010524435A5/ja
Revoked legal-status Critical Current

Links

JP2010501433A 2007-04-03 2008-04-03 種間特異的二重特異性バインダー Revoked JP2010524435A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP07006990 2007-04-03
EP07006988 2007-04-03
US91366807P 2007-04-24 2007-04-24
EP07020641 2007-10-22
EP07020640 2007-10-22
EP07020646 2007-10-22
EP08004741 2008-03-13
PCT/EP2008/002663 WO2008119566A2 (en) 2007-04-03 2008-04-03 Cross-species-specific bispecific binders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013218769A Division JP6016747B2 (ja) 2007-04-03 2013-10-22 種間特異的二重特異性バインダー

Publications (2)

Publication Number Publication Date
JP2010524435A JP2010524435A (ja) 2010-07-22
JP2010524435A5 true JP2010524435A5 (enrdf_load_stackoverflow) 2011-05-19

Family

ID=42582614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010501433A Revoked JP2010524435A (ja) 2007-04-03 2008-04-03 種間特異的二重特異性バインダー

Country Status (8)

Country Link
JP (1) JP2010524435A (enrdf_load_stackoverflow)
DK (1) DK2155788T3 (enrdf_load_stackoverflow)
ES (1) ES2390243T3 (enrdf_load_stackoverflow)
NZ (1) NZ580746A (enrdf_load_stackoverflow)
PT (1) PT2155788E (enrdf_load_stackoverflow)
RS (1) RS52492B (enrdf_load_stackoverflow)
RU (1) RU2535992C2 (enrdf_load_stackoverflow)
SI (1) SI2155788T1 (enrdf_load_stackoverflow)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20130883T4 (hr) * 2007-04-03 2022-11-25 Amgen Research (Munich) Gmbh Međuvrsno specifična cd3-epsilon-vežuća domena
CN101675077B (zh) * 2007-04-03 2013-09-04 安进研发(慕尼黑)股份有限公司 跨种特异性的双特异性结合剂
EP2640750A1 (en) * 2010-11-16 2013-09-25 Boehringer Ingelheim International GmbH Agents and methods for treating diseases that correlate with bcma expression
WO2012158818A2 (en) * 2011-05-16 2012-11-22 Fabion Pharmaceuticals, Inc. Multi-specific fab fusion proteins and methods of use
CA2836857C (en) * 2011-05-21 2019-12-03 Macrogenics, Inc. Cd3-binding molecules capable of binding to human and non-human cd3
SI3736292T1 (sl) 2013-12-17 2024-08-30 Genentech, Inc. Protitelesa proti CD3 in postopki uporabe
KR20170003591A (ko) * 2014-05-28 2017-01-09 에프. 호프만-라 로슈 아게 인간 및 사이노몰구스 cd3 엡실론에 결합하는 항체
JP7020909B2 (ja) * 2014-07-25 2022-02-16 シトムクス セラピューティクス,インコーポレイティド 抗-cd3抗体、活性化可能抗-cd3抗体、多重特異的抗-cd3抗体、多重特異的活性化可能抗-cd3抗体、及びそれらの使用方法
JP6698065B2 (ja) * 2014-07-31 2020-05-27 アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH 組織分布が向上した二重特異性単鎖抗体コンストラクト
EP3778640A1 (en) * 2015-05-01 2021-02-17 Genentech, Inc. Masked anti-cd3 antibodies and methods of use
AU2017233121B2 (en) 2016-03-15 2023-12-21 Itabmed (Hk) Limited Multispecific Fab fusion proteins and use thereof
KR20190074300A (ko) 2016-11-15 2019-06-27 제넨테크, 인크. 항-cd20/항-cd3 이중특이적 항체에 의한 치료를 위한 투약
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
BR112020016169A2 (pt) 2018-02-08 2020-12-15 Genentech, Inc. Moléculas de ligação ao antígeno biespecíficas, ácido nucleico isolado, vetor, célula hospedeira, métodos para produzir a molécula de ligação, conjunto de ácidos nucleicos isolados, conjunto de vetores, conjunto de células hospedeiras, imunoconjugado, composição, uso da molécula de ligação, métodos para tratar ou retardar a progressão de um câncer, métodos para aperfeiçoar a função imune e kit
US20230067182A1 (en) * 2019-11-29 2023-03-02 Boe Technology Group Co., Ltd. Data Processing Device and Method, and Computer Readable Storage Medium
CN114867494B9 (zh) 2019-12-13 2024-01-12 基因泰克公司 抗ly6g6d抗体及使用方法
JP2022087602A (ja) * 2020-12-01 2022-06-13 株式会社バイオピーク 組換え大腸菌による有用タンパク質の生産性を向上するための培養方法
AU2022273541A1 (en) 2021-05-14 2023-11-30 Genentech, Inc. Methods for treatment of cd20-positive proliferative disorder with mosunetuzumab and polatuzumab vedotin
CN115932808B (zh) * 2022-11-04 2025-05-27 四川九洲电器集团有限责任公司 一种基于多特征融合的被动声纳智能探测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2179862C1 (ru) * 2000-12-26 2002-02-27 Общество с ограниченной ответственностью Научно-производственный центр "МедБиоСпектр" Лекарственное средство для предотвращения отторжения трансплантата, моноклональное антитело к cd3-антигену т-лимфоцитов человека, гибридома и способ лечения больных, имеющих реакцию острого отторжения трансплантата после пересадки почки
RU2005137325A (ru) * 2003-05-31 2006-09-10 Микромет Аг (De) Фармацевтическая композиция, содержащая конструкт, специфичный к ерсам
US7235641B2 (en) * 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies
EP1753783B1 (en) * 2004-06-03 2014-08-06 Novimmune SA Anti-cd3 antibodies and methods of use thereof
AU2006291005A1 (en) * 2005-09-12 2007-03-22 Novimmune S.A. Anti-CD3 antibody formulations
US8236308B2 (en) * 2005-10-11 2012-08-07 Micromet Ag Composition comprising cross-species-specific antibodies and uses thereof

Similar Documents

Publication Publication Date Title
JP2010524435A5 (enrdf_load_stackoverflow)
HRP20120759T1 (hr) Bispecifična veziva specifična između vrsta
JP2019501883A5 (enrdf_load_stackoverflow)
FI2155783T4 (fi) Lajien välisesti spesifinen cd3-epsilon-sitoutumisdomeeni
HRP20190932T1 (hr) Molekule protutijela koje se vežu na il-17a i il-17f
JP2022061992A5 (enrdf_load_stackoverflow)
JP2017522892A5 (enrdf_load_stackoverflow)
JP2022079549A5 (enrdf_load_stackoverflow)
TWI769537B (zh) 標靶bcma的抗體、雙專一性抗體及其用途
JP2013528569A5 (enrdf_load_stackoverflow)
CN115003333A (zh) Pvrig结合蛋白及其医药用途
JP2013056885A5 (enrdf_load_stackoverflow)
ME02581B (me) Farmaceutski pripravci s otpornošću na topljivi cea
RU2019128134A (ru) Антитело против gprc5d и молекула, содержащая антитело
JP2018526981A5 (enrdf_load_stackoverflow)
JP2015504306A5 (enrdf_load_stackoverflow)
JP2020510422A5 (enrdf_load_stackoverflow)
JP2018521638A5 (enrdf_load_stackoverflow)
HRP20130883T4 (hr) Međuvrsno specifična cd3-epsilon-vežuća domena
JP2014534242A5 (enrdf_load_stackoverflow)
JP2016511277A5 (enrdf_load_stackoverflow)
JP2016512551A5 (enrdf_load_stackoverflow)
HRP20110187T1 (hr) Multispecifične deimunizirane tvari koje vežu cd3
JP2012504403A5 (enrdf_load_stackoverflow)
JP2016511750A5 (enrdf_load_stackoverflow)